Why predictive retina models could be the future of IND applications

Discover how retina models are revolutionizing rare disease treatment and accelerating drug development.

Optimi Completes Proprietary Natural Psilocybin Extraction Process and Files U.S. Provisional Patent | Psychedelic Finance

VANCOUVER, British Columbia, Aug. 01, 2023 (GLOBE NEWSWIRE) — Optimi Health Corp. (CSE: OPTI) (OTCQX: OPTHF) (FRA: 8BN) (“Optimi” or the “Company”), an end-to-end drug

August 3, 2023

FDA launches pilot programme governing oncology IVD tests – Pharmaceutical Technology

The pilot programme might reduce risk when using LDTs for oncology drug treatment decisions. Image credit: Shutterstock/Tada Images. The US Food and Drug Administration (FDA)

June 22, 2023

Doctors Sue California Over Implicit Bias Training

Two California doctors and a nonprofit filed a lawsuit against top officials of the Medical Board of California (MBC) Tuesday to block a state requirement

August 4, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.